INHIBITORS OF EPHB3 SIGNALING

The present application provides EphB3 kinase inhibitors, useful intreating neurodegenerative or demyelinating diseases or conditions such as autoimmune encephalomyelitis and multiple sclerosis.

Saved in:
Bibliographic Details
Main Authors Quintana, Francisco J, Gutierrez Vazquez, Cristina, Hodgetts, Kevin Julian, Rothhammer, Veit Johannes
Format Patent
LanguageEnglish
Published 13.06.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present application provides EphB3 kinase inhibitors, useful intreating neurodegenerative or demyelinating diseases or conditions such as autoimmune encephalomyelitis and multiple sclerosis.
Bibliography:Application Number: US202218278078